CERN - CERN STOCK NEWS

Cerner Corporation (NASDAQ: CERN) has entered into a partnership with the U.S. Social Security Administration (SSA) to enhance the patient disability benefits claims process. This collaboration focuses on the secure retrieval of electronic health records (EHRs), drastically reducing the transfer time from weeks to mere seconds. Annually, SSA requests over 15 million medical records for disability claims, with current methods being slow and inefficient. This initiative aims to improve access to benefits, reduce administrative burdens, and eventually enhance patient satisfaction.

Oracle Corporation has extended its tender offer to acquire Cerner Corporation until March 16, 2022. The all-cash offer remains at $95.00 per share, unchanged from previous terms. The extension allows additional time for meeting regulatory conditions under the Hart-Scott-Rodino Antitrust Improvements Act. As of February 10, 2022, approximately 14,628,854 shares, or 3.8% of Cerner's outstanding shares, have been tendered. Other terms of the offer remain consistent with the merger agreement.

Cerner Corporation (NASDAQ: CERN) announced a cash dividend of $0.27 per share, marking a 23% increase from the previous $0.22 per share. The dividend will be payable on January 11, 2022, to shareholders of record as of December 27, 2021. Cerner is committed to paying regular quarterly cash dividends, subject to board approval and based on the company’s financial health and operational results.

Cerner Corporation (NASDAQ: CERN) has appointed Dr. Nasim Afsar as its first Chief Health Officer, effective January 2022. Dr. Afsar will oversee over 1,000 healthcare professionals to enhance product development and patient care experiences. Her background includes leadership roles at UCLA Health and UCI Health, with expertise in quality care and health outcomes. CEO David Feinberg expressed excitement about Dr. Afsar's leadership, emphasizing the need to improve healthcare technology for patients and caregivers. The move aims to leverage technology for better health outcomes and operational efficiency.

Transplant Connect and Cerner Corporation have launched a collaboration to automate donor referrals, improving organ, tissue, and eye donation processes. This integration utilizes Transplant Connect's iReferral technology and Cerner's Millennium EHR to streamline the identification and referral of potential donors. Currently tested in five hospitals, this system aims to reduce manual errors and increase timely donations, critical during the COVID-19 pandemic. The collaboration supports U.S. organ procurement organizations, addressing the pressing need for donors, with 17 people dying daily waiting for transplants.

Cerner Corporation (Nasdaq: CERN) reported its third quarter 2021 results, showing a significant increase in adjusted operating margin and adjusted diluted EPS compared to the same quarter last year. However, GAAP operating margin and diluted EPS were lower than previous figures. The company has raised its full-year guidance, indicating a positive outlook for the remainder of the year. Cerner will host a conference call at 8:00 a.m. CT on October 29, 2021, to discuss its results and future prospects.

Cerner Corporation (NASDAQ: CERN) has launched Cerner Enviza, a new operating unit focused on data-driven healthcare solutions. This initiative aims to reduce the average 17-year timeline and $2.5 billion cost for new therapies to reach patients, while promoting equitable participation in clinical trials. By combining resources from Cerner and Kantar Health, the unit seeks to leverage extensive health data to enhance research and therapy development. The goal is to improve patient outcomes through faster, more efficient delivery of healthcare solutions.

Cerner Corporation (Nasdaq: CERN) is set to release its third quarter 2021 earnings results on Oct. 29, before market opening. A conference call will follow at 8 a.m. CT to discuss the results and future outlook, available via dial-in or webcast. The call will include discussions on Cerner’s developments and financial matters. Investors can access the call at (678) 509-7542, passcode: Cerner. More details can be found on Cerner’s website.

Cerner's new President and CEO, David Feinberg, emphasized improving healthcare technology usability during his first keynote at the Cerner Health Conference. He advocates for eliminating unnecessary healthcare noise to enhance patient experiences and outcomes. Cerner's innovations, including the Cerner RevElate for patient accounting, aim to streamline operations for healthcare providers. Feinberg highlighted Gartner's recognition of Cerner's work on clinician burnout and the importance of user-friendly electronic health records (EHR).